Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) shares were down 6.4% during mid-day trading on Thursday . The stock traded as low as GBX 65.50 ($0.84) and last traded at GBX 66 ($0.85). Approximately 84,917 shares were traded during trading, an increase of 100% from the average daily volume of 42,463 shares. The stock had previously closed at GBX 70.50 ($0.90).
Celadon Pharmaceuticals Stock Performance
The stock has a market cap of £39.12 million, a price-to-earnings ratio of -425.00 and a beta of -0.02. The company has a debt-to-equity ratio of 148.29, a current ratio of 2.62 and a quick ratio of 6.97. The stock’s 50-day moving average is GBX 85.69 and its 200-day moving average is GBX 94.52.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Featured Stories
- Five stocks we like better than Celadon Pharmaceuticals
- Earnings Per Share Calculator: How to Calculate EPS
- Why This Banking Stock Might Be Nearing the Bottom of Its Cycle
- Business Services Stocks Investing
- MarketBeat Week in Review – 7/8 – 7/12
- Overbought Stocks Explained: Should You Trade Them?
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
